Locally administrered low-dose alendronate increases bone mineral density during distraction osteogenesis in a rabbit model

Journal of Bone and Joint Surgery - Series B

Volumn 89, Issue 7, 2007, Pages 984-988

  Omi, Hirotsugu ^a   Kusumi, T ^a   Kijima, H ^a   Toh, S ^a  

^a HIROSAKI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; SODIUM CHLORIDE; BONE DENSITY CONSERVATION AGENT;

ANALYSIS OF VARIANCE; ANIMAL TISSUE; ARTICLE; BONE DENSITY; CONTROLLED STUDY; DISTRACTION OSTEOGENESIS; IMAGE ANALYSIS; LOW DRUG DOSE; MALE; NONHUMAN; OSSIFICATION; PRIORITY JOURNAL; RABBIT; TIBIA OSTEOTOMY; ANIMAL; BIOLOGICAL MODEL; METHODOLOGY; OSTEOTOMY;

ALENDRONATE; ANIMALS; BONE DENSITY CONSERVATION AGENTS; MODELS, BIOLOGICAL; OSTEOGENESIS, DISTRACTION; OSTEOTOMY; RABBITS;

EID: 34548237684     PISSN: 0301620X     EISSN: None     Source Type: Journal    
DOI: 10.1302/0301-620X.89B7.18980     Document Type: Article

References (22)

1. Paley D, Catagni M, Argnani F, et al. Treatment of congenital pseudoarthritis of the tibia using the Ilizarov technique. Clin Orthop 1992;280:81-93.
2. Atkins RM, Sudhakar JE, Porteous AJ. Distraction osteogenesis through high energy fractures. Injury 1998;29:535-7.
3. Tsuchiya H, Abdel-Wanis ME, Sakurakichi K, Yamashro T, Tomita K. Osteosarcoma around the knee: intraepiphyseal excision and biological reconstruction with distraction osteogenesis. J Bone Joint Surg [Br] 2002;84-B:1162-6.
4. Aldegheri R. Femoral callotasis. J Pediatr Orthop B 1997;16:42-7.
5. Curran AR, Kuo KN, Lubicky JP. Simultaneous ipsilateral femoral and tibial lengthening with the Ilizarov method. J Pediatr Orthop 1999;19:386-90.
6. Hamdy RC, Amako M, Beckman L, et al. Effects of osteogenic protein-1 on distraction osteogenesis in rabbits. Bone 2003;33:248-55.
7. Chan CW, Qin L, Lee KM, et al. Dose-dependent effect of low-intensity pulsed ultrasound on callus formation during rapid distraction osteogenesis. J Orthop Res 2006;24:2072-9.
8. Sato M, Grasser W, Endo N, et al. Bisphosphonate action: alendronate localization in rat bone and effects on osteoclast ultrastructure. J Clin Invest 1991;88:2095-105.
9. Russell RG, Rogers MJ. Bisphosphonates: from the laboratory to the clinic and back again. Bone 1999;25:97-106.
10. Fleisch H. Bisphosphonates: pharmacology and use in the treatment of tumour-induced hypercalcaemic and metastatic bone disease. Drugs 1991;42:919-44.
11. Seeman E. Osteoporosis: trials and tribulations. Am J Med 1997;103:74-87.
12. Glorieux FH, Bishop NJ, Plotkin H, et al. Cyclic administration of pamidronate in children with severe osteogenesis imperfecta. N Engl J Med 1998;339:947-52.
13. Little DG, Cornell MS, Briody J, et al. Intravenous pamidronate reduces osteoporosis and improves formation of the regenerate during distraction osteogenesis: a study in immature rabbits. J Bone Joint Surg [Br] 2001;83-B:1069-74.
14. Little DG, Smith NC, Williams PR, et al. Zoledronic acid prevents osteopenia and increases bone strength in a rabbit model of distraction osteogenesis. J Bone Miner Res 2003;18:1300-7.
15. Marx RE. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg 2003;61:1115-17.
16. Evans KD, Lau ST, Oberbauer AM, Martin RB. Alendronate affects long bone length and growth plate morphology in the oim mouse model for osteogenesis imperfecta. Bone 2003;32:268-74.
17. Yaffe A, Binderman I, Breuer E, Pinto T, Golomb G. Disposition of alendronate following local delivery in a rat jaw. J Periodontol 1999;70:893-5.
18. No authors listed. Hirosaki University School of Medicine: the Guidelines for Animal Experimentation of Hirosaki University. 2002:1-45.
19. Yaffe A, Iztkovich M, Earon Y, et al. Local delivery of an amino bisphosphonate prevents the resorptive phase of alveolar bone following mucoperiosteal flap surgery in rats. J Periodontol 1997;68:884-9.
20. Amanat N, Brown R, Bilston LE, Little DG. A single systemic dose of pamidronate improves bone mineral content and accelerates restoration of strength in a rat model of fracture repair. J Orthop Res 2005;23:1029-34.
21. Cao Y, Mori S, Mashiba T, et al. Raloxifene, estrogen, and alendronate affect the processes of fracture repair differently in ovariectomized rats. J Bone Miner Res 2002;17:2237-46.
22. Smith EJ, McEvoy A, Little DG, et al. Transient retention of endochondral cartilaginous matrix with bisphosphonate treatment in a long-term rabbit model of distraction osteogenesis. J Bone Miner Res 2004;19:1698-705.